Retacrit (epoetin alfa-epbx)

Manufacturer:

Pfizer

Route of Administration:

Subcutaneous, Intravenous

Site of Care:

Outpatient

Website:

Manufacturer Website

phone:

Enrollment Forms:

Synergen Prescription Form

Patient Support Form

Approved Indication:

treatment of anemia due to chronci kidney disease in patients on dialysis and not on dialysis
treatment of anemia due to zidovudine in patients with HIV infection
treatment of anemia due to the effects of concomitant myelosuppressive chemotherapy (upon initiation, a minimum of two additional months of planned chemotherapy required)
reducing allogenic red blood cell transfusions in patients undergoing elective, noncardiac, nonvascular surgery

Conditions:

Anemia

Therapeutic Area:

Nephrology
Oncology